Scienion and Genomica expand collaboration to provide a new innovative printing technology for multiple applications.
Dr. Holger Eickhoff, CEO of Scienion AG, stated: “The technologies of our companies optimally complement one another. Genomica has an excellent track record of successfully marketed DNA-based IVD tests and with its CLART® technology products the company is considered a benchmark in molecular diagnostics. Combining this expertise with Scienion’s state of the art non-contact dispensing technology, our consumables such as high quality microtiter plates and our production capabilities adds up to a perfect match. We are aiming to speed up the development of better and safer in vitro diagnostics and will offer joint technology solutions for the benefit of users and last but not least also for patients.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.